Alpha Paradigm Partners’s Tandem Diabetes Care TNDM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
Sell
-14,157
Closed -$838K 630
2022
Q2
$838K Buy
14,157
+13,991
+8,428% +$1.15M 0.35% 91
2022
Q1
$19K Buy
+166
New +$19.4K 0.01% 511

Other funds holding TNDM

Alpha Paradigm Partners's TNDM Position: Q3 2022 in Review

Alpha Paradigm Partners sold out of Tandem Diabetes Care (TNDM) in Q3 2022, closing a stake of 14,157 shares — an estimated $838K sold.

Alpha Paradigm Partners first reported a position in TNDM in Q1 2022 and held it in 2 quarters. The position peaked at $838K in Q2 2022. 299 funds tracked by Wall St. Rank hold TNDM as of Q3 2022.

  • Alpha Paradigm Partners reported no remaining Tandem Diabetes Care position as of Q3 2022 after selling out during the quarter.
  • Alpha Paradigm Partners sold 14,157 Tandem Diabetes Care shares in Q3 2022, an estimated $838K.
  • Alpha Paradigm Partners first reported a position in Tandem Diabetes Care in Q1 2022 and held it in 2 quarters.
  • Alpha Paradigm Partners's Tandem Diabetes Care position peaked at $838K in Q2 2022.
  • 299 funds tracked by Wall St. Rank held Tandem Diabetes Care as of Q3 2022.

Based on Alpha Paradigm Partners's 13F filing for Q3 2022, filed 15 Nov 2022.